Intravascular volume expansion

Intravascular volume expansion refers to an increase in the circulating blood plasma volume within a patient’s vascular system. It is not a single molecule or receptor but rather a physiological state achieved through intravenous administration of fluids known as volume expanders. These are typically classified as crystalloids (aqueous mineral salt solutions) or colloids (solutions containing larger molecules like proteins). The primary goal is restoration or maintenance of adequate circulatory blood flow and tissue perfusion following losses due to bleeding, dehydration, shock states, sepsis, burns/injuries—or during surgery. While essential for acute management of hypovolemia and shock states, inappropriate use can lead to complications such as fluid overload—particularly relevant in chronic heart failure where optimal intravascular volumes must be carefully managed. In summary: "Intravascular volume expansion" describes a therapeutic intervention/outcome rather than an individual drug target molecule/receptor.

Other names

Plasma volume expansionBlood volume expansionVolume expander therapy (contextual, not a molecular target)

Drugs/fluids used for intravascular volume expansion act by increasing the fluid content within the vascular compartment. This can be achieved by direct addition of isotonic fluids (crystalloids) or by using colloid solutions that increase oncotic pressure and draw water into the vasculature from interstitial spaces.